KALA BIO is a clinical-stage biopharmaceutical company developing MSC-S therapies for rare and serious eye diseases.[1]
Get notified the moment KALA BIO, Inc. (KALA) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.